Jun 26 |
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
|
Jun 26 |
Haleon to sell overseas nicotine therapy business to Dr. Reddy’s
|
Jun 3 |
Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities
|
May 28 |
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
|
May 22 |
Alvotech and Dr Reddy’s partner to commercialise AVT03
|
May 21 |
Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
|
May 21 |
Alvotech and Dr. Reddy’s collaborate for commercialization of denosumab
|
May 9 |
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
|
May 8 |
Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript
|
May 8 |
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
|